> SERIES A CLOSED. 4 MCHF INVESTED IN TOTAL IN PB&B

> SERIES B OPENING SOON

 

WE WELCOME VENTURE CAPITAL, STRATEGIC INVESTORS, AND FAMILY OFFICES TO CONTACT US DIRECTLY.

 

If you have question first look at the FAQ or send us a message using the contact form.

INVESTMENT CASE

 

  • – PB&B owns 100% of its IP; no royalty nor equity stakes taken by academic partners or third parties on PB&B’s IP
  • – Recession proof global market with double digit growth
  • – Platform technology with applications in facial aging & body remodeling with a strong IP position – Medical Aesthetics is a field with the least new technology companies & innovations
  • – Novel medical Aesthetic technology typically acquired in the billion dollar range
  • – PB&B considered by Plastic Surgeons at the technology the replacement to autologous fat transfer procedures
  • – PB&B gained the financial & logistical support of the Swiss federal & local state government economic promotion office for scientific innovation. PB&B has won multiple national & international prizes & nominations for its scientific innovations

 

Contact us now

plant growing